Medicine capable of resisting atherosclerosis and preparation method thereof

Abstract

The invention provides a medicine capable of resisting atherosclerosis and a preparation method thereof. The medicine comprises the following components in parts by weight: 20-30 parts of puer tea, 20-30 parts of hawthorn fruits, 10-20 parts of feverfew, 10-20 parts of pericarpium citri reticulatae and 10-20 parts of fructus mume. The preparation method of the medicine comprises the following steps: step A, taking puer tea, hawthorn fruits, feverfew, pericarpium citri reticulatae and fructus mume according to the formula; and step B, extracting effective components of puer tea, hawthorn fruits, feverfew, pericarpium citri reticulatae and fructus mume, and preparing the effective components into powder, pills or decoctions. The medicine has a high As-resisting effect, can be used for improving lipid metabolism disorder, platelet abnormal state, insulin abnormality and abnormally-increased DNA methylation level and reducing the weight of patients; the raw materials of the medicine are commonly-used food materials, so that the medicine is free of toxic and side effect and untoward effect.

Description

technical field [0001] The invention relates to the field of traditional Chinese medicine, in particular to an anti-atherosclerosis medicine and a preparation method thereof. Background technique [0002] Atherosclerosis (Atherosclerosis, As), as the common pathological basis of cardiovascular and cerebrovascular diseases, has long been one of the focuses and hotspots in the field of cardiovascular disease research. As is also the main cause of disability and death of cardiovascular diseases. Therefore, the prevention of As is very important for the treatment of patients with cardiovascular disease and the improvement of long-term prognosis. In addition, patients with As are often accompanied by abnormal platelet activity and abnormal insulin levels. Thromboxane A2 (thromboxane, TXA2) is one of the prostaglandins, which is produced by platelets and has platelet aggregation and vasoconstriction effects. It is opposite to prostaglandin I2 (PGI2), and the dynamic balance betwe...

AI Technical Summary

Problems solved by technology

[0003] However, due to changes in lifestyle, especially dietary patterns, insulin resistance occurs in patients, and obesity, abnormal insulin levels, and hyperlipidemia often occur, that is, metabolic syndrome. Drugs with platelet status are rare, and the only drugs (for example, atorvastatin calcium) have toxic and side effects, and are often accompanied by adverse reactions; Drugs to prevent and improve As have a broad market

Images